Morphic Holding, Inc.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF…
Biotechnology
US, Waltham [HQ]
Balance Sheet
7 Sheets · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | 23.00 | 189.00 | 247.00 | 242.00 | 426.00 | 368.00 | 722.00 | |
|
Current
|
21.00 | 187.00 | 243.00 | 239.00 | 418.00 | 362.00 | 716.00 | |
| Cash And Equivalents | 20.00 | 185.00 | 101.00 | 228.00 | 408.00 | 59.00 | 58.00 | |
| Assets | 23.00 | 189.00 | 247.00 | 242.00 | 426.00 | 368.00 | 722.00 | |
| Accounts Receivables (AR) | - - | - - | -3.00 | -3.00 | 5.00 | 1.00 | - - | |
| Inventory | - - | - - | - - | -7.00 | -2.00 | - - | - - | |
| Short Term Investments | - - | - - | 135.00 | 126.00 | 236.00 | 288.00 | 645.00 | |
| Other Current Assets | - - | 1.00 | 3.00 | 11.00 | 10.00 | 13.00 | 12.00 | |
|
Non Current
|
2.00 | 2.00 | 3.00 | 2.00 | 7.00 | 6.00 | 5.00 | |
| Property, Plant, Equipment (Net) | 1.00 | 1.00 | 3.00 | 2.00 | 7.00 | 5.00 | 4.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Assets | - - | - - | - - | - - | - - | - - | - - | |
| Liabilities | 52.00 | 241.00 | 106.00 | 97.00 | 89.00 | 19.00 | 25.00 | |
|
Current
|
2.00 | 34.00 | 35.00 | 39.00 | 38.00 | 17.00 | 24.00 | |
| Accounts Payable | - - | - - | 3.00 | -1.00 | - - | -1.00 | 3.00 | |
| Short Term Debt | - - | - - | - - | -29.00 | 1.00 | 1.00 | 1.00 | |
| Deferred Revenue | - - | 29.00 | 23.00 | 25.00 | 20.00 | - - | -1.00 | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | 1.00 | 3.00 | 6.00 | 39.00 | 11.00 | 11.00 | 17.00 | |
|
Non Current
|
50.00 | 206.00 | 71.00 | 57.00 | 51.00 | 2.00 | - - | |
| Long Term Debt | - - | - - | - - | - - | 3.00 | 2.00 | - - | |
| Leasing Obligations | - - | - - | - - | - - | 5.00 | 3.00 | 2.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | -51.00 | - - | - - | |
| Other Non Current Liabilities | 50.00 | 140.00 | - - | - - | 51.00 | - - | - - | |
| Equity | -29.00 | -52.00 | 140.00 | 145.00 | 336.00 | 349.00 | 697.00 | |
| Stockholders' Equity | -29.00 | -52.00 | 140.00 | 145.00 | 336.00 | 349.00 | 697.00 | |
| Retained Earnings | -30.00 | -54.00 | -97.00 | -142.00 | -238.00 | -297.00 | -449.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | 247.00 | - - | - - | - - | - - | |
| Profit | -16.00 | -23.00 | -43.00 | -44.00 | -94.00 | -59.00 | -152.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 1.00 | 2.00 | -9.00 | 287.00 | 575.00 | 649.00 | 1,143.00 | |
| Loss Other Compr. Income | - - | -1.00 | - - | - - | - - | -3.00 | 2.00 |